AU2001284521A1 - Method of screening hypoglycemic substance by using stat inhibitory factor-1 - Google Patents

Method of screening hypoglycemic substance by using stat inhibitory factor-1

Info

Publication number
AU2001284521A1
AU2001284521A1 AU2001284521A AU8452101A AU2001284521A1 AU 2001284521 A1 AU2001284521 A1 AU 2001284521A1 AU 2001284521 A AU2001284521 A AU 2001284521A AU 8452101 A AU8452101 A AU 8452101A AU 2001284521 A1 AU2001284521 A1 AU 2001284521A1
Authority
AU
Australia
Prior art keywords
inhibitory factor
stat
screening
hypoglycemic substance
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284521A
Inventor
Tadamitsu Kishimoto
Tetsuji Naka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001284521A1 publication Critical patent/AU2001284521A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001284521A 2000-09-11 2001-09-11 Method of screening hypoglycemic substance by using stat inhibitory factor-1 Abandoned AU2001284521A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000274531 2000-09-11
JP2000-274531 2000-09-11
PCT/JP2001/007879 WO2002022813A1 (en) 2000-09-11 2001-09-11 Method of screening hypoglycemic substance by using stat inhibitory factor-1

Publications (1)

Publication Number Publication Date
AU2001284521A1 true AU2001284521A1 (en) 2002-03-26

Family

ID=18760278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284521A Abandoned AU2001284521A1 (en) 2000-09-11 2001-09-11 Method of screening hypoglycemic substance by using stat inhibitory factor-1

Country Status (7)

Country Link
US (1) US7247424B2 (en)
EP (1) EP1318194B1 (en)
JP (1) JP4820527B2 (en)
AU (1) AU2001284521A1 (en)
CA (1) CA2421907C (en)
DE (1) DE60142974D1 (en)
WO (1) WO2002022813A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098510A2 (en) * 2003-04-30 2004-11-18 Beth Israel Deaconess Medical Center Cystic fibrosis therapy
US7981915B2 (en) * 2003-04-30 2011-07-19 Beth Israel Deaconess Medical Center Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440860A (en) * 1980-01-18 1984-04-03 The Children's Medical Center Corporation Stimulating cell growth
EP0989186B1 (en) 1997-01-10 2006-05-03 Tadamitsu Kishimoto Novel stat function-regulatory protein

Also Published As

Publication number Publication date
EP1318194A4 (en) 2005-03-02
US7247424B2 (en) 2007-07-24
CA2421907A1 (en) 2003-03-10
JP4820527B2 (en) 2011-11-24
CA2421907C (en) 2009-12-15
EP1318194B1 (en) 2010-09-01
EP1318194A1 (en) 2003-06-11
JPWO2002022813A1 (en) 2004-01-22
US20030186215A1 (en) 2003-10-02
DE60142974D1 (en) 2010-10-14
WO2002022813A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU2001231104A1 (en) Methods for treating diabetes
AU2002242996A1 (en) Spiroisoquinoline compounds, methods for their preparation and intermediates
AU2003214055A1 (en) Method for screening for compounds having hdac inhibitory activity
AU2002228590A1 (en) Method of harvesting sugarcane
AU2001284521A1 (en) Method of screening hypoglycemic substance by using stat inhibitory factor-1
AU2003222364A1 (en) Preparation for oxidation-sensitive compounds and method for making same
AU2001274415A1 (en) Quality control of data
AU2002247215A1 (en) Method for screening compounds
AU2001230365A1 (en) Method of screening compounds for biological activity
AU2002214954A1 (en) Process for the preparation of phenylphenol compounds
AU2002216032A1 (en) Method of analysing microporous material
AU1211900A (en) Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans
AU4856501A (en) Screening method for compounds
AU2002224122A1 (en) Method of screening remedy for diabetes
AU2003243432A1 (en) Process of making phosphordiamidite compounds
AU2001276370A1 (en) Process for the preparation of pesticidal compounds
AU2001236293A1 (en) Compensation for linear filtering using frequency weighting factors
AU2003289566A1 (en) Preparation method of 1,5-dimethyltetralin
AU2002354247A1 (en) Screening method
AU2001278729A1 (en) Method of screening remedy for heart failure
AU1981100A (en) Method of screening for agrochemicals
AU2002335165A1 (en) Method of examining type i diabetes
AU2474897A (en) Process for the preparation of 5-(alkoxymethyl)-2,3-pyridinedicarboximide compounds
AU2002300513A1 (en) Method of Border Management
AU2002354206A1 (en) Method of screening drug